CAC
WGSWW

Cowen and Company’s GeneDx Holdings Warrant WGSWW Stock Holding History

Cowen and Company’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-800,658
Closed -$59.9K – 310
2024
Q3 		$59.9K Sell
800,658
-59,070
-7% -$2.04K ﹤0.01% 328
2024
Q2 		$25.5K Sell
859,728
-200
-0% -$7 ﹤0.01% 377
2024
Q1 		$47.3K Sell
859,928
-278,160
-24% -$10.9K ﹤0.01% 358
2023
Q4 		$11.4K Buy
1,138,088
+11,498
+1% +$171 ﹤0.01% 387
2023
Q3 		$33.7K Sell
1,126,590
-9,384
-0.8% -$261 ﹤0.01% 323
2023
Q2 		$11.7K Hold
1,135,974
– – ﹤0.01% 384
2023
Q1 		$21K Buy
1,135,974
+100
+0% +$2 ﹤0.01% 302
2022
Q4 		$21.6K Buy
1,135,874
+1,106,400
+3,754% +$114K ﹤0.01% 332
2022
Q3 		$7K Buy
+29,474
New +$8.27K ﹤0.01% 468

Other funds holding WGSWW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Cowen and Company's WGSWW Position: Q4 2024 in Review

Cowen and Company sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2024, closing a stake of 800,658 shares — an estimated $59.9K sold.

Cowen and Company first reported a position in WGSWW in Q3 2022 and held it in 9 quarters. The position peaked at $59.9K in Q3 2024. 17 funds tracked by Wall St. Rank hold WGSWW as of Q4 2024.

  • Cowen and Company reported no remaining GeneDx Holdings Warrant position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 800,658 GeneDx Holdings Warrant shares in Q4 2024, an estimated $59.9K.
  • Cowen and Company first reported a position in GeneDx Holdings Warrant in Q3 2022 and held it in 9 quarters.
  • Cowen and Company's GeneDx Holdings Warrant position peaked at $59.9K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.